Xu BH - Search Results

1

[Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor].

Qi L, Mo HN, Chen XL, Wang X, Wu DW, Lan B, Li Q, Wang XY, Xu JP, Yang Q, Xu BH, Huang J. Qi L, et al. Among authors: xu jp, xu bh. Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):772-775. doi: 10.3760/cma.j.issn.0253-3766.2018.10.009. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30392342 Clinical Trial. Chinese.

2

[The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy].

Tang JL, Huang J, Wang X, Chen XL, Li Q, Mo HN, Wu DW, Lan B, Xu BH. Tang JL, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2019 Jun 23;41(6):466-470. doi: 10.3760/cma.j.issn.0253-3766.2019.06.013. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31216835 Clinical Trial. Chinese.

3

[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].

Ou KP, Li Q, Luo Y, Lyu JJ, Zhou H, Yang Y, Cai YJ, Wang ZJ, Wang X, Qi LQ, Ma F, Xu BH. Ou KP, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2020 Nov 23;42(11):966-971. doi: 10.3760/cma.j.cn112152-20200224-00122. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33256310 Clinical Trial. Chinese.

4

[Efficacy and survival outcomes of dose-dense carboplatin plus paclitaxel as neoadjuvant chemotherapy for triple-negative breast cancer].

Liu Y, Xiu M, Wang X, Li Q, Wang JY, Fan Y, Li Q, Chen SS, Cai RG, Mo HN, Ma F, Luo Y, Xu BH, Zhang P. Liu Y, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2022 Feb 23;44(2):178-184. doi: 10.3760/cma.j.cn112152-20210705-00496. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35184463 Chinese.

5

[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer].

Wang ZJ, Han YQ, Li Q, Mo HN, Li YQ, Guan XW, Chen YM, Lin SY, Xu BH, Li Q, Zhang P, Ma F. Wang ZJ, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2022 Apr 23;44(4):360-363. doi: 10.3760/cma.j.cn112152-20200409-00325. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35448925 Chinese.

6

[Clinicopathological features and prognosis of HER2-negative luminal-type breast cancer patients with early and late recurrence].

Chen XL, Fan Y, Xu BH. Chen XL, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2016 Jun 23;38(6):448-53. doi: 10.3760/cma.j.issn.0253-3766.2016.06.009. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27346403 Chinese.

7

[The treatment and prognosis of peripheral primitive neuroectodermal tumor].

Lan B, Wang L, Xu BH, Huang J. Lan B, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):850-854. doi: 10.3760/cma.j.issn.0253-3766.2017.11.008. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29151292 Chinese.

8

[Feasibility and toxicity of EC-T dose-dense adjuvant chemotherapy: A real world study in Chinese early-stage breast cancer patients with high recurrence risk].

Wang JN, Mu YX, Li Q, Fan Y, Wang JY, Ma F, Luo Y, Yuan P, Chen SS, Li Q, Cai RG, Zhang P, Xu BH. Wang JN, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2019 May 23;41(5):368-372. doi: 10.3760/cma.j.issn.0253-3766.2019.05.009. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31137171 Chinese.

9

[Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel coronavirus disease].

Liu BL, Ma F, Wang JN, Fan Y, Mo HN, Xu BH. Liu BL, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):288-291. doi: 10.3760/cma.j.cn112152-20200221-00110. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32100979 Chinese.

10

[Progress on clinical trials of cancer drugs in China, 2019].

Huang HY, Wu DW, Wang HX, Wang J, Fan Q, Wang SH, Bai Y, Yu Y, Fang Y, Sun C, Fang H, Bai H, Wang X, Liu ZY, Jiang M, Liu Z, Wang XH, Li HY, Li N, Cao C, Xu BH, Sun Y, He J. Huang HY, et al. Among authors: xu bh. Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):127-132. doi: 10.3760/cma.j.issn.0253-3766.2020.02.008. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32135647 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters